间质性肺疾病的定量CT测量:两个厂商间的同日变异性——一项前瞻性研究
前瞻性研究纳入2023年1月至11月诊断的48例间质性肺疾病患者,同日先后用GE和西门子设备行两次胸部CT,比较纤维化评分的厂商间变异性。肺与B60f核组合的纤维化评分平均原始差值为-0.80%(95% LOA,-3.4%至1.8%),CCC为0.989,显示高度一致。
要点
- 纤维化评分在肺与B60f核组合的厂商间平均原始差值为-0.80%,95% LOA为-3.4%至1.8%。
- 骨与B50f核组合的纤维化评分厂商间平均原始差值最小(0.11%;95% LOA,-1.3%至1.5%)。
- 所有厂商间核组合的纤维化评分CCC为0.953-0.998,呈高度至几乎完美一致。
核心结论
- 使用各厂商用于肺部评估的主要高频核重建时,两个不同厂商系统同日CT检查的QCT纤维化评分变异性小(平均原始差值-0.80%)。
研究设计与样本
- 前瞻性研究,招募2023年1月至11月诊断的间质性肺疾病患者48例(男43例、女5例,平均年龄67.8±5.2岁),同日先后使用GE Discovery CT750 HD和西门子Somatom Definition AS+行两次平扫胸部CT,间隔约15分钟。
诊断标准与关键数值
- 纤维化评分计算为网状不透明影和蜂窝状改变体积百分比之和,使用商用深度学习软件进行QCT分析。
- 肺核与B60f核组合的纤维化评分平均原始差值为-0.80%(95% LOA,-3.4%至1.8%),CCC为0.989。
- 骨核与B50f核组合的纤维化评分平均原始差值最小为0.11%(95% LOA,-1.3%至1.5%)。
- 肺核与B30f核组合的纤维化评分平均原始差值最大为-2.52%(95% LOA,-6.5%至1.4%),95% LOA最宽。
- 所有厂商间核组合的纤维化评分CCC为0.953-0.998,呈高度至几乎完美一致。
临床应用与阅片要点
- 不同厂商的QCT纤维化评分在结合预期测量变异性解读时,可能对间质性肺疾病的纵向评估有信息价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Clinical application of quantitative CT (QCT) measurements of interstitial lung disease (ILD) for longitudinal monitoring of disease progression requires an understanding of how such measurements vary across vendors. OBJECTIVE. The purpose of this study was to evaluate same-day variability between vendors for QCT measurements of fibrosis extent in patients with ILD. METHODS. This prospective study recruited participants with ILD diagnosed from January 2023 to November 2023. Participants underwent two serial unenhanced chest CT examinations on the same day using scanners from two different vendors (Discovery CT750 HD [GE HealthCare] and Somatom Definition AS+ [Siemens Healthineers]), with examinations separated by approximately 15 minutes. Examinations were reconstructed using three kernels (lung, chest, and bone) from GE Healthcare and three kernels (B60f, B50f, and B30f) from Siemens Healthineers. The lung and B60f kernels represented each vendor's primary high-frequency kernel for ILD evaluation. Commercially available deep learning-based software was used for QCT analysis. The fibrosis score was calculated as the sum of reticular opacity and honeycombing volume percentages. Intervendor variability was assessed using the Bland-Altman method, and agreement was assessed using the concordance correlation coefficient (CCC). RESULTS. The study included 48 participants (43 men and five women; mean age, 67.8 ± 5.2 [SD] years). The mean fibrosis score for the lung and B60f kernels was 12.64% and 11.84%, respectively. For the fibrosis score, the mean raw difference ranged from a minimum for the bone-B50f kernel pair (0.11%; 95% limits of agreement [LOA], -1.3% to 1.5%) to a maximum for the lung-B30f kernel pair (-2.52%; 95% LOA, -6.5% to 1.4%). The lung-B60f kernel pair showed a mean raw difference of -0.80% (95% LOA, -3.4% to 1.8%). The 95% LOA was narrowest for the bone-B50f kernel pair and widest for the lung-B30f kernel pair. The fibrosis score demonstrated substantial to almost perfect agreement across all intervendor kernel combinations (CCC, 0.953-0.998), including almost perfect agreement for the lung-B60f kernel pair (CCC, 0.989). CONCLUSION. QCT-derived fibrosis scores showed small variability (mean raw difference, -0.80%) for same-day CT examinations performed using systems from two different vendors when reconstructed with each vendor's primary high-frequency kernel for lung evaluation. CLINICAL IMPACT. QCT-derived fibrosis scores across different vendors may be informative for longitudinal assessment of ILD when interpreted in the context of expected measurement variability.
引用
- Ahn Y, Lee SM, Kim Y, et al. Quantitative CT Measurements of Interstitial Lung Disease: Same-Day Variability Between Two Vendors-A Prospective Study. AJR Am J Roentgenol. 2025. PMID: 41474222. doi:10.2214/AJR.25.34057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。